Your browser doesn't support javascript.
loading
Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment.
Parsons, Joshua B; Westgeest, Annette C; Conlon, Brian P; Fowler, Vance G.
Afiliação
  • Parsons JB; Department of Medicine, Division of Infectious Disease, Duke University Medical Center, Durham, NC 27710, USA.
  • Westgeest AC; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Conlon BP; Department of Medicine, Division of Infectious Disease, Duke University Medical Center, Durham, NC 27710, USA.
  • Fowler VG; Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Antibiotics (Basel) ; 12(3)2023 Feb 24.
Article em En | MEDLINE | ID: mdl-36978320
Methicillin-resistant Staphylococcus aureus (MRSA) is a devastating pathogen responsible for a variety of life-threatening infections. A distinctive characteristic of this pathogen is its ability to persist in the bloodstream for several days despite seemingly appropriate antibiotics. Persistent MRSA bacteremia is common and is associated with poor clinical outcomes. The etiology of persistent MRSA bacteremia is a result of the complex interplay between the host, the pathogen, and the antibiotic used to treat the infection. In this review, we explore the factors related to each component of the host-pathogen interaction and discuss the clinical relevance of each element. Next, we discuss the treatment options and diagnostic approaches for the management of persistent MRSA bacteremia.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article